The Use of Embolic Protection Devices Is Associated With a Lower Stroke and Death Rate After Carotid Stenting

作者：Knappich Christoph; Kuehnl Andreas; Tsantilas Pavlos; Schmid Sofie; Breitkreuz Thorben; Kallmayer Michael; Zimmermann Alexander; Eckstein Hans Henning^*

来源：JACC: Cardiovascular Interventions , 2017, 10(12): 1257-1265.

DOI：10.1016/j.jcin.2017.03.032

• carotid artery disease
• carotid artery stenting
• death
• embolic protection device
• stroke

OBJECTIVES The aim of this study was to analyze the association between intraprocedural and periprocedural variables and in-hospital stroke or death rate after carotid artery stenting.
BACKGROUND In Germany, all open surgical and endovascular procedures on the extracranial carotid artery must be documented in a statutory nationwide quality assurance database.
METHODS A total of 13,086 carotid artery stenting procedures for asymptomatic (63.9%) or symptomatic carotid stenosis (mean age 69.7 years, 69.7% men) between 2009 and 2014 were recorded. The following variables were analyzed: stent design, stent material, neurophysiological monitoring, periprocedural antiplatelet medication, and use of an embolic protection device. The primary outcome was in-hospital stroke or death. Major stroke or death, any stroke, and death, all until discharge, were secondary outcomes. Adjusted relative risks (RRs) were assessed using multilevel multivariable regression analyses.
RESULTS The primary outcome occurred in 2.4% of the population (1.7% in asymptomatic and 3.7% in symptomatic patients). The multivariable analysis showed an independent association between the use of an embolic protection device and lower in-hospital rates of stroke or death (adjusted RR: 0.65; 95% confidence interval [CI]: 0.50 to 0.85), major stroke or death (adjusted RR: 0.60; 95% CI: 0.43 to 0.84), and stroke (adjusted RR: 0.57; 95% CI: 0.43 to 0.77). Regarding the occurrence of in-hospital death, there was no significant association (adjusted RR: 0.78; 95% CI: 0.46 to 1.35). None of the outcomes was associated with stent design, stent material, neurophysiological monitoring, or antiplatelet medication.
CONCLUSIONS The use of an embolic protection device was independently associated with lower in-hospital risk for stroke or death, major stroke or death, and stroke.

• 出版日期2017-6-26